Jeremy Sussman
Jeremy Sussman
University of Michigan and VA Ann Arbor Healthcare System
Verified email at
Cited by
Cited by
Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials
DM Zulman, JB Sussman, X Chen, CT Cigolle, CS Blaum, RA Hayward
Journal of general internal medicine 26 (7), 783-790, 2011
Evidence-based risk communication: a systematic review
DA Zipkin, CA Umscheid, NL Keating, E Allen, KK Aung, R Beyth, S Kaatz, ...
Annals of internal medicine 161 (4), 270-280, 2014
Effect of patients’ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus
S Vijan, JB Sussman, JS Yudkin, RA Hayward
JAMA internal medicine 174 (8), 1227-1234, 2014
Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care
TJ Iwashyna, JF Burke, JB Sussman, HC Prescott, RA Hayward, ...
American journal of respiratory and critical care medicine 192 (9), 1045-1051, 2015
An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials
JB Sussman, RA Hayward
Bmj 340, 2010
Three simple rules to ensure reasonably credible subgroup analyses
JF Burke, JB Sussman, DM Kent, RA Hayward
Bmj 351, 2015
Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus
JB Sussman, EA Kerr, SD Saini, RG Holleman, ML Klamerus, LC Min, ...
JAMA internal medicine 175 (12), 1942-1949, 2015
Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis
V Chopra, DH Wesorick, JB Sussman, T Greene, M Rogers, JB Froehlich, ...
Archives of Surgery 147 (2), 181-189, 2012
Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk
S Yadlowsky, RA Hayward, JB Sussman, RL McClelland, YI Min, S Basu
Annals of internal medicine 169 (1), 20-29, 2018
Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis
S Basu, JS Yudkin, S Kehlenbrink, JI Davies, SH Wild, KJ Lipska, ...
The lancet Diabetes & endocrinology 7 (1), 25-33, 2019
Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program
JB Sussman, DM Kent, JP Nelson, RA Hayward
Bmj 350, 2015
Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials
S Basu, JB Sussman, SA Berkowitz, RA Hayward, JS Yudkin
The lancet Diabetes & endocrinology 5 (10), 788-798, 2017
Improved cardiovascular risk prediction using nonparametric regression and electronic health record data
EH Kennedy, WL Wiitala, RA Hayward, JB Sussman
Medical care 51 (3), 251, 2013
Using benefit-based tailored treatment to improve the use of antihypertensive medications
J Sussman, S Vijan, R Hayward
Circulation 128 (21), 2309-2317, 2013
Benefit and harm of intensive blood pressure treatment: derivation and validation of risk models using data from the SPRINT and ACCORD trials
S Basu, JB Sussman, J Rigdon, L Steimle, BT Denton, RA Hayward
PLoS medicine 14 (10), e1002410, 2017
Validation of risk equations for complications of type 2 diabetes (RECODe) using individual participant data from diverse longitudinal cohorts in the US
S Basu, JB Sussman, SA Berkowitz, RA Hayward, AG Bertoni, A Correa, ...
Diabetes care 41 (3), 586-595, 2018
Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis
BJ Elmunzer, AG Singal, JB Sussman, AR Deshpande, DA Sussman, ...
Gastrointestinal endoscopy 81 (3), 700-709. e3, 2015
Sex differences in cognitive decline among US adults
DA Levine, AL Gross, EM Briceņo, N Tilton, BJ Giordani, JB Sussman, ...
JAMA network open 4 (2), e210169-e210169, 2021
Detecting heterogeneous treatment effects to guide personalized blood pressure treatment: a modeling study of randomized clinical trials
S Basu, JB Sussman, RA Hayward
Annals of internal medicine 166 (5), 354-360, 2017
Serum NfL (neurofilament light chain) levels and incident stroke in adults with diabetes mellitus
FK Korley, J Goldstick, M Mastali, JE Van Eyk, W Barsan, WJ Meurer, ...
Stroke 50 (7), 1669-1675, 2019
The system can't perform the operation now. Try again later.
Articles 1–20